CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4–TGFα–EGFR signaling
- DOI
- 10.1186/s11658-025-00690-1
- Published
- 2025-01-30
- Container
- Cellular & Molecular Biology Letters
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s11658-025-00690-1,
title = {CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4–TGFα–EGFR signaling},
author = {Xindong Wei and Anfeng Si and Shuai Zhao and Yi Fu and Jilei Li and Kedeerya Aishanjiang and Yujie Ma and Chang Yu and Bo Yu and Chunhong Cui and Hui Wang and Xianming Kong and Shibo Li and Xiaoni Kong and Ying Tong and Hailong Wu},
year = {2025},
journal = {Cellular \& Molecular Biology Letters},
doi = {10.1186/s11658-025-00690-1},
url = {https://doi.org/10.1186/s11658-025-00690-1}
}RIS
TY - JOUR TI - CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4–TGFα–EGFR signaling AU - Xindong Wei AU - Anfeng Si AU - Shuai Zhao AU - Yi Fu AU - Jilei Li AU - Kedeerya Aishanjiang AU - Yujie Ma AU - Chang Yu AU - Bo Yu AU - Chunhong Cui AU - Hui Wang AU - Xianming Kong AU - Shibo Li AU - Xiaoni Kong AU - Ying Tong AU - Hailong Wu PY - 2025 JO - Cellular & Molecular Biology Letters DO - 10.1186/s11658-025-00690-1 UR - https://doi.org/10.1186/s11658-025-00690-1 ER -
APA
Wei, X., Si, A., Zhao, S., Fu, Y., Li, J., Aishanjiang, K., Ma, Y., Yu, C., Yu, B., Cui, C., Wang, H., Kong, X., Li, S., Kong, X., Tong, Y., & Wu, H. (2025). CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4–TGFα–EGFR signaling. Cellular & Molecular Biology Letters. https://doi.org/10.1186/s11658-025-00690-1
Source records
- crossref · retrieved 2026-09-26T08:55:49.403Z